Substantia Nigra Pars Reticulata Projections to the Pedunculopontine Nucleus Modulate Dyskinesia

Area of Science:

• Neuroscience
• Basal Ganglia Research
• Optogenetics

Background:

• Long-term levodopa treatment for Parkinson's disease (PD) can cause motor complications like levodopa-induced dyskinesia (LID).
• The substantia nigra pars reticulata (SNr) and globus pallidus internal segment (GPi) are key basal ganglia output nuclei implicated in PD and LID.
• Dysregulation of SNr and GPi activity is central to Parkinson's disease pathophysiology and the development of LID.

Purpose of the Study:

• To investigate if direct modulation of SNr GABAergic neurons and their projections to the pedunculopontine nucleus (PPN) can regulate PD symptoms and LID.
• To explore the therapeutic potential of targeting SNr-PPN pathways for managing Parkinson's disease motor complications.

Main Methods:

• Utilized optogenetic tools (channelrhodopsin-2 and halorhodopsin) delivered via AAV vectors in Vgat-IRES-Cre mice.
• Employed a 6-hydroxydopamine model of PD to assess the effects of modulating SNr GABAergic neuron activity.
• Evaluated akinesia and LID using behavioral tasks, including the forepaw stepping task, mouse LID rating scale, and open-field locomotion.

Main Results:

• Suppression of SNr neuron activity with halorhodopsin effectively improved akinesia.
• Activation of SNr neurons with channelrhodopsin-2 significantly reduced LID without compromising levodopa's antiakinetic effects.
• Optogenetic stimulation of SNr projections to the PPN mimicked the effects of direct SNr stimulation.

Conclusions:

• Modulating SNr GABAergic neurons impacts akinesia and LID, aligning with the rate model of basal ganglia circuitry.
• SNr projections to the PPN appear to mediate the antidyskinetic effects of increased SNr neuronal activity.
• This study identifies a potential novel role for the PPN in the mechanisms underlying LID.